A Clinical Study of Darcilil Combined With AI Combined With Pyrrotinib in the Treatment of TPBC

Abroad (travel likely)Recruiting

Conditions

Breast Neoplasms

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

The Second Affiliated Hospital of Soochow University, Suzhou, Jiangsu, China
Contact: Study coordinator (Hui Wang) · whuisd@163.com · 13913501391
Contact: Study coordinator (Shushu Zhang) · xyzss567@163.com · 18936081534

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Study Of Capecitabine Combined With Camrelizumab For Non-pCR TNBC With TLS After Neoadjuvant Chemoterapy

Breast Neoplasms

Abroad (travel likely)RecruitingPHASE3

Guangzhou, China

A Study of BMS-986340 as Monotherapy and as Combination Therapy in Participants With Advanced Solid Tumors

Cervical Cancer · Gastric/Gastroesophageal Junction Adenocarcinoma · Microsatellite Stable Colorectal Cancer

IsraelRecruitingPHASE1, PHASE2

Clovis, United States · Los Angeles, United States

Dalpiciclib With or Without Entinostat and Letrozole in HR+/HER2- Early Breast Cancer

Breast Cancer

Abroad (travel likely)RecruitingPHASE2

Shijiazhuang, China